Stevia First Corp. Announces Pilot-Scale Testing of

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Stevia First Corp. Announces Pilot-Scale Testing of Domestic Stevia Extraction

SACRAMENTO, CA--(Marketwired - May 7, 2013) - Stevia First Corp. ( OTCQB : STVF ) ("Stevia First" or the "Company"), an early-stage agribusiness based in California's Central Valley growing region and focused on the industrial scale production of stevia, the all-natural zero-calorie sweetener that is rapidly transforming the food and beverage industry, is pleased to announce that efforts aimed at developing domestic stevia extraction methods have reached pilot-scale functionality and continue to progress toward commercial production capability.

As an agricultural biotechnology company devoted to the production of stevia extract, the development of fermentation technologies has evolved as the primary focus and key value driver for the organization. Stevia First's investment in pilot-scale stevia extraction equipment and related internal research is focused on demonstrating domestic stevia extraction methods that are economical and that can rapidly be incorporated into a modern, scalable stevia production system. Technologies being deployed are designed to be improvements over the stevia industry as it exists today, which was developed as long as 20 or 30 years ago in China and Japan, catering to the Japanese introduction of stevioside as a sweetener in the 1970s. The process of stevia extraction involves the separation of steviol glycosides from other substances, and it is required for traditional leaf-based production as well as modern fermentation-based production methods.

Pilot stage systems are generally used to reduce the risk associated with construction of larger-scale production facilities and to better define key parameters of innovative processes. Aiming directly at meeting or exceeding California's stringent food safety and environmental standards, which serve to attract multinational companies to adopt domestic stevia for use in new food and beverage products, Stevia First is employing specialized, sanitary, food-grade equipment for much of the pilot-scale development work.

"Our plans for an industrial-scale stevia production system in the United States are already well under way," states Company CEO Robert Brooke. "Momentum is building towards this goal, and we expect this to continue as we execute on fermentation-based stevia production milestones, and provide additional evidence that key engineering targets are being met."

About Stevia First Corp. ( OTCQB : STVF ) Stevia First Corp. is seeking to establish a vertically-integrated enterprise in the U.S. that uses technological expertise in fermentation-based stevia production and improves upon traditional stevia farming and processing methods. Stevia First's U.S. operations are located in the heart of California's Central Valley, one of the world's most productive agricultural regions. For more information visit: www.steviafirst.com .

About the Stevia Industry The market for all-natural, zero-calorie stevia sweeteners is expanding rapidly. The World Health Organization (WHO) estimates stevia intake could eventually replace 20-30% of all dietary sweeteners. The total global sweetener market was estimated at $58.3 billion in 2010. For more information visit: www.steviafirst.com .

Notice Regarding Forward-Looking Statements This news release contains "forward-looking statements" as that term is defined in Section 27(a) of the United States Securities Act of 1933, as amended and Section 21(e) of the Securities Exchange Act of 1934, as amended. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, projections of worldwide sales of stevia products, growth of stevia production and global markets. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects and development stage companies. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-K for the most recent fiscal year, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission.

Contact: Investor Relations Stevia First Corporation Email: info@stevia-first.com Tel: +1- (530) 231-7800 Web: www.steviafirst.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

M&A Source's 2026 Conference Tackles Deal-Making Drama

Updated Category News Views 84

High Stakes and Deep Insights Await in Houston Cracking the nut of lower-middle market transactions ain’t a walk in the park. M&A Source®'s Fall 2026 Conference is gearing up to address the very dramas that lurk behind the scenes. Kicking off November 2-4 at the opulent JW Marriott in Houston, Texas, the event is looking to assemble a heavyweight lineup of...

Continue Reading
Co-Diagnostics Nearing India TB Test Launch By 2026

Updated Category News Views 98

Co-Diagnostics Gears Up for Indian TB Test Market Picture this: Co-Diagnostics, a molecular diagnostics player, is on the brink of a significant leap toward expanding its footprint in India with its TB test. The stage is set, with a clinical study already turning in results as solid as old boots. We're talking sensitivity hovering around 97.3% and specificity at...

Continue Reading
Tamara Toles O'Laughlin: Steering Philanthropy's Next Era

Updated Category News Views 52

Leadership Transition in Philanthropy Everyone knows the drill: leadership changes are often a toss-up. You could get a fresh burst of energy or spend years longing for the good old days. That's where The New York Women's Foundation finds itself as they hand over the reins from Ana L. Oliveira to Tamara Toles O'Laughlin. In a world where philanthropic shifts can either...

Continue Reading
Fairfax Crest: A New Chapter in Affordable Housing

Updated Category News Views 31

Setting the Stage: Fairfax Crest's Grand Opening You know what's better than leaving a dusty old car park underutilized? Turning it into homes for folks who really need them. That's exactly what went down in Fairfax County as they cut the ribbon on their latest affordable housing project, Fairfax Crest. We're talking 279 affordable units sprouting up where there once lay...

Continue Reading
Hisense's AI S7 Dishwasher Revolutionizes Home Living

Updated Category News Views 75

The Intersection of AI and Home Appliances In a world where families are looking for more efficiency, Hisense isn’t just tossing another dishwasher into the wild. No, they're aiming to redefine the whole damn experience of household chores with their latest brainchild, the Hisense S7 Dishwasher. Packed with AI smarts and an impressive tech bouquet, this bad boy is all...

Continue Reading
Personalis Merger Faces Investigation: $16.25 Offers Scrutinized

Updated Category News Views 38

Market Storm or Light Drizzle? When the sharks smell blood or the legal eagles start circling, you know something stinks. BFA Law is sniffing around, and it isn’t just for sport. They’re putting their magnifying glass on this curious $16.25 per share transaction where Tempus AI plans to gobble up Personalis lock, stock, and barrel. For investors holding NASDAQ:PSNL,...

Continue Reading
XCMG Climbs Fortune China 500: Strengthens Global Edge

Updated Category News Views 83

XCMG's Ascent on the Fortune China 500 When it comes to scaling new heights, XCMG Machinery is clearly in the driver's seat, roaring up the Fortune China 500 to claim the 202nd spot, leaping ten ranks from last year. While others may coast, XCMG's trajectory is anything but idle, retaining its crown among Chinese construction machinery titans. The recent summit in Chengdu...

Continue Reading
Common Thread Advisors: Transforming Change in Business

Updated Category News Views 41

Navigating the Storm of Change: A New Player in Town You know, just when you think you've got the business world figured out, something sharp comes along. Today, it’s Common Thread Advisors, making its grand entrance to help organizations steer through the dense fog of change. This isn’t your everyday, run-of-the-mill consultancy. No sir, they’re out here with a...

Continue Reading
Bybit’s Gold Yield Offer: 2.83% APR on XAUT

Updated Category News Views 74

Gold Savings with a Tokenized Twist Taking a wild swing at pairing gold and crypto in a digestible package, Bybit and the XAUE Protocol have teamed up to offer a 2.83% fixed APR on XAUT Savings. If you're itching for something that doesn’t make your stomach churn like some of the wild crypto rides, this just might soothe those nerves. Or maybe it’s just a slick way to...

Continue Reading
Fluence Faces Legal Battle Amid Major Stock Plunge

Updated Category News Views 55

The High Stakes for Fluence Energy Investors Well, here's a plot twist, or perhaps not for those who've been keeping an eye on the renewable energy sector. Fluence Energy (NASDAQ:FLNC), a supposed heavyweight in energy storage and renewable innovations, is tangled in a legal web over securities fraud. As of now, Fluence has been slapped with a class action lawsuit...

Continue Reading

Top 5 Most Recently Viewed Articles

Economic Impact of Trump's Trade Deal: What Comes Next?

Updated Category News Views 270

Trade Deal Analysis and Its Implications President Donald Trump’s recent trade agreement with the European Union has sparked a wave of criticism from economists across the board. The general consensus among experts is that the deal could have adverse effects on American consumers and businesses alike. Insights from Notable Economists Economist Peter Schiff shared his...

Continue Reading
Innovative Navigation Solutions from NAL Research and Partners

Updated Category News Views 369

Strategic Collaboration Enhances Maritime Navigation In an exciting partnership, NAL Research, a leader in Assured Positioning, Navigation, and Timing (APNT) solutions, has joined forces with SGM Technology AS and Tschudi Shipping Company to create innovative navigation and tracking solutions tailored for the commercial maritime sector. This collaboration aims to tackle...

Continue Reading
Global Ready-Mix Concrete Market Set for Remarkable Growth

Updated Category News Views 187

Ready-mix Concrete Market Overview Ready-mix concrete (RMC) is reshaping global construction with a projected size of USD 1824.29 billion by 2033, according to recent insights. In 2025, it's estimated at USD 989.25 billion, reflecting a robust compound annual growth rate (CAGR) of 8.06% from 2026 to 2033. This growth can be credited to rampant urbanization, robust...

Continue Reading
NevGold Reports Strong Antimony Recovery at Limo Butte Project

Updated Category News Views 105

Positive Metallurgical Test Results from NevGold Vancouver, British Columbia – NevGold Corp. (“NevGold” or the “Company”) (TSXV: NAU) (OTCQX: NAUFF) (Frankfurt: 5E50) is excited to share impressive results from its recent metallurgical testwork at the Limousine Butte Project. This site has gained recognition as a promising area for mining, particularly for its...

Continue Reading
Exploring Arbutus Biopharma's Financial Success and Future Ahead

Updated Category News Views 192

Arbutus Biopharma Posts Strong Financial Results Arbutus Biopharma Corporation (NASDAQ: ABUS) reported a notable total revenue of $10.7 million for the second quarter of 2025, representing a significant increase compared to previous earnings. This financial growth encompasses deferred revenue linked to the reacquisition of rights to imdusiran, an innovative treatment the...

Continue Reading